Estrella Immunopharma Warrant
ESLAW
8 hedge funds and large institutions have $236K invested in Estrella Immunopharma Warrant in 2026 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 1 closing their positions.
1.25% less ownership
Funds ownership: 23.66% → 22.4% (-1.3%)
11% less funds holding
Funds holding: 9 → 8 (-1)
33% less capital invested
Capital invested by funds: $354K → $236K (-$118K)
50% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 2
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CS
Clear Street
New York
|
+$8 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RSWM
Robertson Stephens Wealth Management
San Francisco,
California
|
-$1.05K |
| 2 |
LCM
Landscape Capital Management
Englewood,
New Jersey
|
-$684 |
| 3 |
YCM
Yakira Capital Management
Westport,
Connecticut
|
-$15 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
BFM
1
Boothbay Fund Management
New York
| $201K | – | – | – |
|
|
RSWM
2
Robertson Stephens Wealth Management
San Francisco,
California
| $12.7K | -$1.05K | -14,000 | -54% |
|
3
D.E. Shaw & Co
New York
| $6.13K | – | – | – |
|
|
SIA
4
SkyView Investment Advisors
Shrewsbury,
New Jersey
| $5K | – | – | – |
|
|
YCM
5
Yakira Capital Management
Westport,
Connecticut
| $3.47K | -$15 | -200 | -0.4% |
|
|
WA
6
Whitebox Advisors
Minneapolis,
Minnesota
| $3.17K | – | – | – |
|
|
CS
7
Clear Street
New York
| $2.55K | +$8 | +100 | +0.3% |
|
8
Toronto Dominion Bank
Toronto, Ontario,
Ontario, Canada
| $1.62K | – | – | – |
|
|
LCM
9
Landscape Capital Management
Englewood,
New Jersey
| – | -$684 | -13,682 | Closed |
|
ESLAW Hedge Fund Activity: Q1 2026 in Review
8 of the 8,130 institutional investors tracked by Wall St. Rank reported a position in Estrella Immunopharma Warrant (ESLAW) for Q1 2026, worth a combined $236K — down 33% from $354K a quarter earlier.
Sellers outnumbered buyers: 1 fund closed out of ESLAW and 0 opened new positions — a net loss of 1 holder — while 2 trimmed existing stakes and 1 added.
The largest buyer was Clear Street, adding an estimated $8. The largest seller was Robertson Stephens Wealth Management, cutting an estimated $1.05K.
- 8 institutional investors held Estrella Immunopharma Warrant (ESLAW) as of Q1 2026, down from 9 in Q4 2025.
- Funds reported $236K of Estrella Immunopharma Warrant stock for Q1 2026, down 33% quarter-over-quarter.
- 0 funds opened new Estrella Immunopharma Warrant positions in Q1 2026 and 1 closed out, a net change of -1 holder.
- The largest Estrella Immunopharma Warrant buyer in Q1 2026 was Clear Street, an estimated $8 added.
- The largest Estrella Immunopharma Warrant seller in Q1 2026 was Robertson Stephens Wealth Management, an estimated $1.05K sold.
Based on aggregated 13F filings for Q1 2026.